These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31965185)

  • 1. Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database.
    Lenert A; Oh G; Ombrello MJ; Kim S
    Rheumatology (Oxford); 2020 Jul; 59(7):1725-1733. PubMed ID: 31965185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological study of adult-onset Still's disease using a Japanese administrative database.
    Sakata N; Shimizu S; Hirano F; Fushimi K
    Rheumatol Int; 2016 Oct; 36(10):1399-405. PubMed ID: 27502500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
    Bindoli S; Galozzi P; Doria A; Sfriso P
    Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients.
    Bodard Q; Langlois V; Guilpain P; Le Quellec A; Vittecoq O; Noel D; Eble V; Josse S; Schmidt J; Aouba A; Levesque H; Le Besnerais M; Benhamou Y
    J Autoimmun; 2021 Jan; 116():102541. PubMed ID: 32943282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
    Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
    Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra for the treatment of adult-onset Still's disease.
    Castañeda S; Atienza-Mateo B; Martín-Varillas JL; Serra López-Matencio JM; González-Gay MA
    Expert Rev Clin Immunol; 2018 Dec; 14(12):979-992. PubMed ID: 30324816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease.
    Ruscitti P; Natoli V; Consolaro A; Caorsi R; Rosina S; Giancane G; Naddei R; Di Cola I; Di Muzio C; Berardicurti O; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Cipriani P; Gattorno M; Giacomelli R; Ravelli A
    Rheumatology (Oxford); 2022 Oct; 61(10):4124-4129. PubMed ID: 35078234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
    Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
    Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, characteristics, treatments, and outcomes of adult-onset Still's disease in Afro-Caribbeans: Results from a population-based study in Martinique, French West Indies.
    de Fritsch E; Louis-Sidney F; Felix A; Moinet F; Bagoée C; Henry K; Wolff S; Polomat K; Dramé M; Deligny C; Suzon B
    J Autoimmun; 2023 Sep; 139():103086. PubMed ID: 37356346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
    Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
    Goda K; Kenzaka T; Hoshijima M; Yachie A; Akita H
    Rheumatol Int; 2020 Jan; 40(1):145-152. PubMed ID: 31541282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Japanese Patients with Elderly-Onset Adult-Onset Still's Disease.
    Suzuki E; Temmoku J; Fujita Y; Yashiro-Furuya M; Asano T; Kanno T; Migita K
    Tohoku J Exp Med; 2021 Nov; 255(3):195-202. PubMed ID: 34759075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
    Vanderschueren S; Hermans F; De Munter P; Knockaert D
    Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis.
    Zhang Y; Yang Y; Bai Y; Yang D; Xiong Y; Zeng X
    Clin Rheumatol; 2016 May; 35(5):1145-51. PubMed ID: 26809798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
    Horiuchi Y; Hashimoto K; Horikoshi H; Sano A; Kawamura Y; Fujita N; Kimata M; Ono Y; Obuchi Y; Makino A; Kaneko M; Kimura F; Itoh K; Tanaka Y
    Medicine (Baltimore); 2022 Jul; 101(28):e29354. PubMed ID: 35839054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.